Cargando…
The increased release of amino acid neurotransmitters of the primary somatosensory cortical area in rats contributes to remifentanil-induced hyperalgesia and its inhibition by lidocaine
BACKGROUND: Studies have confirmed that activation of the neurons of primary somatosensory cortex (S1) is involved in the process of remifentanil (Remi)-induced hyperalgesia (RIH), which can be suppressed by lidocaine (Lido). A total intravenous anesthesia model of rats mimicking clinical Remi-based...
Autores principales: | Wang, Shanshan, Cui, Weihua, Zeng, Min, Ren, Yi, Han, Song, Li, Junfa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6097504/ https://www.ncbi.nlm.nih.gov/pubmed/30147356 http://dx.doi.org/10.2147/JPR.S168008 |
Ejemplares similares
-
Effect of intraoperative infusion of ketamine on remifentanil-induced hyperalgesia
por: Choi, Eunji, et al.
Publicado: (2015) -
Thalamocortical circuits drive remifentanil-induced postoperative hyperalgesia
por: Jin, Yan, et al.
Publicado: (2022) -
Pain-related neuronal ensembles in the primary somatosensory cortex contribute to hyperalgesia and anxiety
por: Ishikawa, Tatsuya, et al.
Publicado: (2023) -
Antihyperalgesic effects of dexmedetomidine on high-dose remifentanil-induced hyperalgesia
por: Lee, Cheol, et al.
Publicado: (2013) -
Spinal ephrinB/EphB signalling contributed to remifentanil-induced hyperalgesia via NMDA receptor
por: Xia, WS, et al.
Publicado: (2014)